QDL-14240-96027
3 vaccinations
1 coded response
25 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 787 / TX
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Registered in v-safe
-
2021-04-13
Dose 1 — Moderna
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-05-11
Dose 2 — Moderna
- 2021-05-11
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-05-13
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-08-10
- 2021-11-09
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2022-05-11
-
2022-11-23
Survey response — 12 months, dose 3MedDRA: Nasal congestion, Productive cough, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe nasal and chest congestion. Mild fever for 24 hours, breaking on its own. Lasting productive cough for more than 2 weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Moderna | |
| 2 | 2021-05-11 | Moderna | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 12 months, dose 3
Symptoms: Severe nasal and chest congestion. Mild fever for 24 hours, breaking on its own. Lasting productive cough for more than 2 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release